Persistence of uropathogenic Escherichia Coli in the bladders of female patients with sterile urine after antibiotic therapies

Abstract

This study aimed to provide evidence of persistent uropathogenic Escherichia coli (UPEC) in female patients with recurrent urinary tract infection (UTI) after antibiotic therapy. We collected biopsies of the bladder, and clean-catch urine samples from 32 women who had episodes of recurrent UTI and were given antibiotic therapy. Urine samples and biopsies were analyzed by conventional bacteriological techniques. Phylogenetic group and 16 virulence factors (VFs) of UPEC were determined using polymerase chain reaction (PCR). The infection capability of UPEC was confirmed in a mouse model. Immunofluorescence and electron microscopy were used to detect intracellular bacterial communities (IBCs) in the mouse model. The results showed that all urine specimens were detected sterile. E. coli was found in 6 of 32 biopsies (18.75%), and was identified to be UPEC by PCR. Different VFs associated with the formation of IBCs were identified in all six UPEC isolates. Each UPEC isolate was capable of forming IBCs within the bladder epithelial cells of mice. In conclusion, UPEC with distinctive pathological traits and the capability of IBC formation was first found in the bladders of women after antibiotic therapy, suggesting that the IBC pathogenic pathway may occur in humans and it plays an important role in UTI recurrence.

Keywords

urinary tract infection / intracellular bacterial communities / uropathogenic Escherichia coli / persistence

References

[1] LiuX, ChenZ, YeZ. Etiological study on cystitis glandularis caused by bacterial infection. J Huazhong Univ Sci Technol [Med Sci], 2007, 27(6): 678-680

[2] ChenZ, LanR, YeZ, et al. . Analysis on pathogenesis of 50 cases of bladder proliferative lesions. J Huazhong Univ Sci Technol [Med Sci], 2003, 23(3): 294-296

[3] FoxmanB. Recurring urinary tract infection: Incidence and risk factors. Am J Public Health, 1990, 80(3): 331-333 PMID: 2305919 PMCID: 1404686

[4] ScholesD, HootonTM, RobertsPL, et al. . Risk factors for recurrent urinary tract infection in young women. J Infect Dis, 2000, 182(4): 1177-1182 PMID: 10979915

[5] RonaldA, NicolleL, StammE, et al. . Urinary tract infection in adults: Research priorities and strategies. Int J Antimicrob Agents, 2001, 17(4): 343-348 PMID: 11295419

[6] RonaldA. The etiology of urinary tract infection: Traditional and emerging pathogens. Dis Mon, 2003, 49(2): 71-82 PMID: 12601338

[7] AndersonGG, PalermoJJ, SchillingJD, et al. . Intracellular bacterial biofilm-like pods in urinary tract infections. Science, 2003, 301(5629): 105-107 PMID: 12843396

[8] AndersonGG, DodsonKW, HootonTM, et al. . Intracellular bacterial communities of uropathogenic escherichia coli in urinary tract pathogenesis. Trends Microbiol, 2004, 12(9): 424-430 PMID: 15337164

[9] JusticeSS, HungC, TheriotJA, et al. . Differentiation and developmental pathways of uropathogenic escherichia coli in urinary tract pathogenesis. Proc Natl Acad Sci USA, 2004, 101(5): 1333-1338 PMID: 14739341 PMCID: 337053

[10] GarofaloCK, HootonTM, MartinSM, et al. . Escherichia coli from urine of female patients with urinary tract infections is competent for intracellular bacterial community formation. Infect Immun, 2007, 75(1): 52-60 PMID: 17074856

[11] MysorekarIU, HultgrenSJ. Mechanisms of uropathogenic escherichia coli persistence and eradication from the urinary tract. Proc Natl Acad Sci USA, 2006, 103(38): 14170-14175 PMID: 16968784 PMCID: 1564066

[12] MulveyMA, SchillingJD, HultgrenSJ. Establishment of a persistent escherichia coli reservoir during the acute phase of a bladder infection. Infect Immun, 2001, 69(7): 4572-4579 PMID: 11402001 PMCID: 98534

[13] SchillingJD, LorenzRG, HultgrenSJ. Effect of trimethoprim-sulfamethoxazole on recurrent bacteriuria and bacterial persistence in mice infected with uropathogenic escherichia coli. Infect Immun, 2002, 70(12): 7042-7049 PMID: 12438384 PMCID: 132990

[14] BlangoMG, MulveyMA. Persistence of uropathogenic escherichia coli in the face of multiple antibiotics. Antimicrob Agents Chemother, 2010, 54(5): 1855-1863 PMID: 20231390 PMCID: 2863638

[15] JohnsonJR. Virulence factors in escherichia coli urinary tract infection. Clin Microbiol Rev, 1991, 4(1): 80-128 PMID: 1672263 PMCID: 358180

[16] JohnsonJR, StellAL. Extended virulence genotypes of escherichia coli strains from patients with urosepsis in relation to phylogeny and host compromise. J Infect Dis, 2000, 181(1): 261-272 PMID: 10608775

[17] ClermontO, BonacorsiS, BingenE. Rapid and simple determination of the escherichia coli phylogenetic group. Appl Environ Microbiol, 2000, 66(10): 4555-4558 PMID: 11010916 PMCID: 92342

[18] JohnsonJR, KuskowskiMA, OwensK, et al. . Phylogenetic origin and virulence genotype in relation to resistance to fluoroquinolones and/or extendedspectrum cephalosporins and cephamycins among escherichia coli isolates from animals and humans. J Infect Dis, 2003, 188(5): 759-768 PMID: 12934193

[19] BowerJM, EtoDS, MulveyMA. Covert operations of uropathogenic escherichia coli within the urinary tract. Traffic, 2005, 6(1): 18-31 PMID: 15569242 PMCID: 2523259

[20] RosenDA, HootonTM, StammWE, et al. . Detection of intracellular bacterial communities in human urinary tract infection. PLoS Med, 2007, 4(12): 329

[21] RobinoL, ScavoneP, AraujoL, et al. . Detection of intracellular bacterial communities in a child with escherichia coli recurrent urinary tract infections. Pathog Dis, 2013, 68(3): 78-81 PMID: 23733378

[22] RobinoL, ScavoneP, AraujoL, et al. . Intracellular bacteria in the pathogenesis of escherichia coli urinary tract infection in children. Clin Infect Dis, 2014, 59(11): e158-164 PMID: 25091303 PMCID: 4650771

[23] ElliottTS, ReedL, SlackRC, et al. . Bacteriology and ultrastructure of the bladder in patients with urinary tract infections. J Infect, 1985, 11(3): 191-199 PMID: 3936879

[24] StammWE, CountsGW, RunningKR, et al. . Diagnosis of coliform infection in acutely dysuric women. N Engl J Med, 1982, 307(8): 463-468 PMID: 7099208

[25] HeXL, WangQ, PengL, et al. . Role of uropathogenic escherichia coli outer membrane protein t in pathogenesis of urinary tract infection. Pathog Dis, 2015, 73(3): ftv006 PMID: 25825479

[26] HungC-S, DodsonKW, HultgrenSJ. A murine model of urinary tract infection. Nat Protoc, 2009, 4(8): 1230-1243 PMID: 19644462 PMCID: 2963178

[27] MartinezJJ, MulveyMA, SchillingJD, et al. . Type 1 pilus-mediated bacterial invasion of bladder epithelial cells. EMBO J, 2000, 19(12): 2803-2812 PMID: 10856226 PMCID: 203355

[28] DhakalBK, KulesusRR, MulveyMA. Mechanisms and consequences of bladder cell invasion by uropathogenic escherichia coli. Eur J Clin Invest, 2008, 38(s2): 2-11 PMID: 18616559

[29] MulveyMA. Adhesion and entry of uropathogenic escherichia coli. Cell Microbiol, 2002, 4(5): 257-271 PMID: 12027955

[30] MulveyMA, Lopez-BoadoYS, WilsonCL, et al. . Induction and evasion of host defenses by type 1-piliated uropathogenic escherichia coli. Science, 1998, 282(5393): 1494-1497 PMID: 9822381